About this trial
This study aims to propose a novel, easy-to-operate intervention strategy that effectively improves defecation function after stoma reversal and to assess its impact on the gut microbiota.The efficacy and safety of antegrade placement of probiotics into the distal deserted intestine during prophylactic stoma to improve bowel function after stoma reversal were evaluated through randomized controlled clinical trials.Observing the changes in gut microbiota during the prophylactic stoma period, the impact of probiotics on the structure of gut microbiota, and exploring the correlation between gut genera and bowel function after stoma reversal.
Eligibility criteria
Qualifiers
Age between 18 and 75 years
Ultra low rectal cancer meeting the indication for Intersphincteric Resection (ISR) surgery
Underwent a prophylactic ileostomy
Scheduled for stoma reversal surgery within 6 months after the ISR procedure
Disqualifiers
Does not meet the surgical indications for Intersphincteric Resection (ISR)
Presence of multiple primary colorectal malignancies
Patients who have received neoadjuvant radiotherapy
Patients who experience disease progression or death in the postoperative period
Trial design
Treatments tested in this trial
- Clostridium butyricum (live) Tablets(Meiya)
Treatment groups
Sponsors and collaborators
Huashan Hospital
Lead sponsor
Characteristic Medical Center of Rocket Army
Collaborator
Zhongnan Hospital
Collaborator
The First Affiliated Hospital of Nankai University
Collaborator
First Affiliated Hospital of Fujian Medical University
Collaborator
Ruijin Hospital
Collaborator
Nanfang Hospital, Southern Medical University
Collaborator